Rubius has dosed the first patient in its PKU Phase 1 study. Reminder the timeline on this, maintained well into late 2019, was an early readout by end of last year. The biotech now isn't putting out a timeline on initial data.
$RUBY PR:https://ir.rubiustx.com/news-releases/news-release-details/rubius-therapeutics-announces-first-patient-dosed-phase-1b-trial …
0 replies
1 proslijeđeni tweet
3 korisnika označavaju da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.